A look at Dr. B, a service that will algorithmically match US providers of COVID-19 vaccines who have extra doses with people who want them, now in 30 states
Context & Ripple Effects
Dr. B arrives into a vacuum left by the official rollout infrastructure: the statewide sign-up sites built by Google, Salesforce, and Microsoft struggled with county-system integration, and a subsequent audit of every state's appointment site found privacy and mobile-usability problems. A startup running an algorithmic standby list is the consumer-tech answer to portals that couldn't match supply to people.
It also fits the pattern that follows it in this coverage — Uber adding vaccine-appointment scheduling and rides to Walgreens, then the Biden administration recruiting Tinder, Hinge, and OkCupid as vaccination channels. Dr. B is an early data point in private platforms becoming the distribution layer for pandemic response.
First-order effects
- Providers holding doses at risk of expiring gain a ready queue of nearby takers instead of discarding vials, while people shut out of glitchy state portals get a second entry point in 30 states.
Second-order effects
- State health systems face pressure to fix the usability and privacy gaps the Markup flagged, or cede the last-mile matching function to startups and consumer apps like Uber.
Third-order effects
- If platform-mediated matching keeps outperforming government-built portals, public-health logistics structurally shifts toward private intermediaries — with the corresponding open question of who holds and governs the health data these lists collect.
The trend: Pandemic-response logistics is migrating from government-built portals to private platforms acting as real-time matching layers between supply and demand.